Discussion platform is part of Act EU initiative to improve clinical trial environment
An initiative to improve the environment for conducting clinical trials in the EU has launched a platform to facilitate discussions.
The Accelerating Clinical Trials in the EU initiative, or Act EU, was established in 2022 as a collaboration between the European Medicines Agency, which is the EU regulator, the heads of national medicines agencies and the European Commission.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.